A Double-Blind, Randomized, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Orally Administered SP-303 for the Treatment of Diarrhea in Acquired Immunodeficiency Syndrome (AIDS) Patients
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Ponce, Puerto Rico, 00731
- Hosp Regional de Ponce
-
San Juan, Puerto Rico, 00909
- Clinical Research Puerto Rico Inc
-
-
-
-
Arizona
-
Scottsdale, Arizona, United States, 85251
- Hill Top Research Ltd
-
Scottsdale, Arizona, United States, 85251
- Phoenix Living Ctr
-
-
California
-
Los Angeles, California, United States, 90095
- UCLA CARE Ctr
-
Palo Alto, California, United States, 94304
- AIDS Research Ctr / Dept of Veterans Affairs
-
San Francisco, California, United States, 94110
- San Francisco Gen Hosp
-
West Hollywood, California, United States, 90046
- Lynn House Hospice
-
West Hollywood, California, United States, 90069
- AIDS Research Alliance
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20059
- Howard Univ
-
Washington, District of Columbia, United States, 20060
- GCRC
-
-
Florida
-
Coral Gables, Florida, United States, 33146
- Community CRI of South Florida
-
Maitland, Florida, United States, 32751
- Central Florida Research Initiative
-
Miami, Florida, United States, 33157
- Deering Hosp
-
Orlando, Florida, United States, 32808
- Rosemont Health Care Ctr
-
Tampa, Florida, United States, 33609
- Ctr for Quality Care
-
Tampa, Florida, United States, 33609
- Mem Hosp of Tampa
-
-
Georgia
-
Atlanta, Georgia, United States, 30327
- Phillip Branchman
-
Decatur, Georgia, United States, 30033
- Insite Clinical Trials
-
-
Illinois
-
Oak Park, Illinois, United States, 60304
- Oak Park Hosp
-
-
Indiana
-
Indianapolis, Indiana, United States, 462025250
- Indiana Univ Med Ctr
-
-
Louisiana
-
Kenner, Louisiana, United States, 70062
- New Orleans Pharmaceutical Research
-
-
Maryland
-
Baltimore, Maryland, United States, 212875554
- Johns Hopkins Hosp
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02111
- New England Med Ctr
-
-
Michigan
-
Detroit, Michigan, United States, 48201
- Wayne State Univ
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55415
- Hennepin County Med Ctr
-
St. Paul, Minnesota, United States, 55101
- Regions Hosp
-
-
Missouri
-
St. Louis, Missouri, United States, 63110
- Washington Univ School Of Medicine
-
-
New York
-
Brooklyn, New York, United States, 112123198
- Brookdale Univ Hosp and Med Ctr
-
New York, New York, United States, 10011
- Saint Vincents Hosp
-
-
North Carolina
-
Raleigh, North Carolina, United States, 27610
- Wake Med CRI
-
-
Texas
-
Houston, Texas, United States, 77004
- Joseph Gathe
-
San Antonio, Texas, United States, 78284
- GCRC - VA Hosp
-
San Antonio, Texas, United States, 78284
- South Texas Veterans Health Care System
-
-
Washington
-
Seattle, Washington, United States, 98112
- Bailey Boushay House
-
Seattle, Washington, United States, 98125
- Rosehedge House
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
Patients must have:
- HIV infection meeting CDC criteria for AIDS.
- History of diarrhea for greater than or equal to 14 days prior to screening period (Day 1).
Required:
- On stable medical regimen.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Masking: Double
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immune System Diseases
- Signs and Symptoms, Digestive
- Slow Virus Diseases
- HIV Infections
- Diarrhea
- Acquired Immunodeficiency Syndrome
- Immunologic Deficiency Syndromes
Other Study ID Numbers
Other Study ID Numbers
- 293A
- 37,554-210
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.